Dr. Krasner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
194 Howard St.
New London, CT 06320Phone+1 860-444-3366
Education & Training
Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1991 - 1994- Johns Hopkins UniversityResidency, Internal Medicine, 1988 - 1991
Northwestern University The Feinberg School of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 2021 - 2025
CT State Medical License 2000 - 2018
Publications & Presentations
PubMed
- 94 citationsAntibody Response to Inhaled Insulin in Patients with Type 1 or Type 2 Diabetes. An Analysis of Initial Phase II and III Inhaled Insulin (Exubera) Trials and a Two-Yea...S. Edwin Fineberg, Tom Kawabata, Deborah Finco-Kent, Cameron Liu, Alan Krasner
The Journal of Clinical Endocrinology and Metabolism. 2005-06-01 - 118 citationsImmunological responses to exogenous insulin.S. Edwin Fineberg, Thomas T. Kawabata, Deborah Finco-Kent, Robert J. Fountaine, Gregory L. Finch
Endocrine Reviews. 2007-10-01 - 140 citationsGlucocorticoid-Induced Adrenal InsufficiencyAlan S. Krasner
JAMA. 1999-08-18
Press Mentions
Crinetics Pharmaceuticals Presenting New Data from Open Label Extension Trial of Paltusotine in Acromegaly at the Society for Endocrinology BES CongressNovember 8th, 2021- $-0.40 EPS Expected for Crinetics Pharmaceuticals, Inc. (CRNX)December 14th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
